FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

4650011000036106: Sinemet 250/25 (carbidopa 25 mg + levodopa 250 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3483531000168117 Sinemet 250/25 tablet en Synonym Active Case sensitive Australian Medicines Terminology module
3611611000168110 Sinemet 250/25 (carbidopa 25 mg + levodopa 250 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sinemet 250/25 tablet has manufactured dose form tablet true Inferred relationship Some
Sinemet 250/25 tablet Is a trade product unit of use true Inferred relationship Some
Sinemet 250/25 tablet Is a Sinemet 250/25 true Inferred relationship Some
Sinemet 250/25 tablet Is a levodopa 250 mg + carbidopa 25 mg tablet true Inferred relationship Some
Sinemet 250/25 tablet has manufactured dose form uncoated tablet false Inferred relationship Some
Sinemet 250/25 tablet has intended active ingredient carbidopa true Inferred relationship Some 796584058
Sinemet 250/25 tablet has intended active ingredient levodopa true Inferred relationship Some 1790476988
Sinemet 250/25 tablet has Australian BoSS carbidopa true Inferred relationship Some 796584058
Sinemet 250/25 tablet has Australian BoSS levodopa true Inferred relationship Some 1790476988
Sinemet 250/25 tablet has unit of use tablet true Inferred relationship Some 1790476989

Inbound Relationships Type Active Source Characteristic Refinability Group
Sinemet 250/25 tablet, 100, bottle has TPUU True Sinemet 250/25 tablet Inferred relationship Some 1
Sinemet 250/25 tablet, 100 has TPUU True Sinemet 250/25 tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start